What are the 10 drugs negotiated by Medicare?

A negotiation between Medicare and drug companies will lower prescription costs for users of the federal health insurance program come 2026.

The Biden-Harris administration announced on Thursday an agreement to lower prices for 10 drugs that are some of the most expensive and common in the Medicare program.

Medicare drug price discounts range from 38% to 79% off list prices, according to the US Department of Health and Human Services.

The federal agency estimates Medicare would have saved $6bn (£4.7bn) if the new prices for the 10 drugs were in effect last year.

Here’s what to know about the negotiated drugs:

The negotiated prices will go into effect for those with Medicare prescription drug coverage on 1 Jan. 2026.

Here are the 10 drugs and their negotiated prices for a one-month supply:

• Januvia treats diabetes. The negotiated price is $113 (£103), down 79%.
• Fiasp, Fiasp FlexTouch, Fiasp PenFill, NovoLog, NovoLog FlexPen, NovoLog PenFill: These drugs, which are insulin medications, treat diabetes. The negotiated price is $119, down 76%.
• Farxiga treats diabetes, heart failure and chronic kidney disease. The negotiated price is $178.50, down 68 %.
• Enbrel treats rheumatoid arthritis, psoriasis and psoriatic arthritis. The negotiated price is $2,355, down 67%.
• Jardiance treats diabetes, heart failure and chronic kidney disease. The negotiated price is $197, down 66%.
• Stelara treats psoriasis, psoriatic arthritis, Crohn’s disease and ulcerative colitis. The negotiated price is $4,695, down 66%.
• Xarelto prevents and treats blood clots and reduces risk of coronary or peripheral artery disease. The negotiated price is $197, down 62%.
• Eliquis prevents and treats blood clots. The negotiated price is $23, down 56%.
• Entresto treats heart failure. The negotiated price is $628, down 53%.
• Imbruvica treats blood cancers. The negotiated price is $9,319, down 38%.

Around nine million people with Medicare’s drug prescription plan use at least one of the 10 drugs negotiated, according to the US Department of Health and Human Services.

Some of the drugs – including Eliquis, Xarelto and Jardiance – saw over one million Medicare enrolees file prescriptions for the medications in 2022.

Medicare users who are enrolled in the plan’s prescription drug coverage are eligible to receive the lowered prices.

The prices will go into effect in 2026. Drug companies are required to make the negotiated prices available to individuals, pharmacies and mail-order services.

Those with Medicare prescription drug coverage are expected to save $1.5 billion in out-of-pocket costs in 2026, according to the US Department of Health and Human Services.

Medicare is a federal health insurance program for Americans who are 65 years of age or older. Some individuals with disabilities may also qualify for the program.

It provides coverage to more than 65 million Americans, according to the Centers for Medicare & Medicaid Services.

The program has four parts that provide different types of health coverage. They include:

• Hospital insurance for hospital care and some costs to stay in nursing facilities.
• Medical insurance for doctors visits, laboratory tests, medical equipment, ambulance services and outpatient hospital care.
• Prescription drug coverage for medications.
• Medicare Advantage plans which include a Medicare health plan through a private company.